Bio-Rad Laboratories BIO Share Buybacks
Share Buybacks at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories in its filing.
Tagged under the XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock.
The official record: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Rad Laboratories's share buybacks.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Rad Laboratories's share buybacks?
- Bio-Rad Laboratories (BIO) reported share buybacks of $47.8M in Q1 2026.
- How has Bio-Rad Laboratories's share buybacks changed year-over-year?
- Bio-Rad Laboratories's share buybacks decreased by 53.1% year-over-year, from $101.9M to $47.8M.
- What is the long-term trend for Bio-Rad Laboratories's share buybacks?
- Over 3 years (2022 to 2025), Bio-Rad Laboratories's share buybacks has grown at a 11.1% compound annual growth rate (CAGR), from $215.7M to $295.5M.
- What does share buybacks mean?
- Cash spent by the company to buy back its own shares from the market.
- How do you interpret share buybacks?
- High repurchases signal management's confidence in the company's value and a commitment to returning capital to shareholders.
- How does share buybacks compare across companies?
- Common among mature, cash-generative companies looking to optimize their capital structure.